Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease... Show more
Industry PharmaceuticalsGeneric
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| IAT | 59.41 | 0.84 | +1.43% |
| iShares US Regional Banks ETF | |||
| IGF | 65.99 | 0.29 | +0.44% |
| iShares Global Infrastructure ETF | |||
| GBF | 103.16 | 0.25 | +0.24% |
| iShares Government/Credit Bond ETF | |||
| NXTI | 33.90 | -0.32 | -0.94% |
| Simplify Next Intangible Core Index ETF | |||
| DAT | 41.90 | -0.83 | -1.93% |
| ProShares Big Data Refiners ETF | |||
A.I.dvisor tells us that INDV and SUPN have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that INDV and SUPN's prices will move in lockstep.
| Ticker / NAME | Correlation To INDV | 1D Price Change % | ||
|---|---|---|---|---|
| INDV | 100% | +2.33% | ||
| SUPN - INDV | 30% Poorly correlated | +2.65% | ||
| EBS - INDV | 29% Poorly correlated | -0.63% | ||
| ASRT - INDV | 26% Poorly correlated | +0.15% | ||
| ALKS - INDV | 25% Poorly correlated | +4.31% | ||
| DERM - INDV | 22% Poorly correlated | +2.83% | ||
More | ||||
| Ticker / NAME | Correlation To INDV | 1D Price Change % |
|---|---|---|
| INDV | 100% | +2.33% |
| Pharmaceuticals: Generic industry (83 stocks) | 26% Poorly correlated | -0.28% |
The RSI Indicator for INDV moved out of oversold territory on June 03, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 28 similar instances when the indicator left oversold territory. In of the 28 cases the stock moved higher. This puts the odds of a move higher at .
The Momentum Indicator moved above the 0 level on June 09, 2026. You may want to consider a long position or call options on INDV as a result. In of 88 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
INDV moved above its 50-day moving average on June 03, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where INDV advanced for three days, in of 203 cases, the price rose further within the following month. The odds of a continued upward trend are .
INDV may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.
The Moving Average Convergence Divergence Histogram (MACD) for INDV turned negative on May 15, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 48 similar instances when the indicator turned negative. In of the 48 cases the stock turned lower in the days that followed. This puts the odds of success at .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where INDV declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for INDV entered a downward trend on June 09, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock better than average.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. INDV’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (147.059) is normal, around the industry mean (145.826). P/E Ratio (19.621) is within average values for comparable stocks, (96.212). INDV's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.604). INDV has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.032). P/S Ratio (3.826) is also within normal values, averaging (95.625).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.